Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castration-sensitive prostate cancer patients with osteoporosis

Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castration-sensitive prostate cancer patients with osteoporosis

Abstract Background Androgen deprivation therapy (ADT) is the effective treating prostate cancer but is often accompanied by cancer treatment-induced bone loss (CTIBL), which impairs the patient’s quality of life. In patients with nonmetastatic castration-sensitive prostate cancer (M0CSPC) who alrea...

Full description

Bibliographic Details
Main Authors: Daisuke Watanabe, Takahiro Kimura, Ken Watanabe, Hiromitsu Takano, Yuko Uehara, Tadaaki Minowa, Akemi Yamashita, Seiichiro Yoshikawa, Akio Mizushima
Format: Article
Language:English
Published: BMC 2021-04-01
Series:BMC Cancer
Online Access:https://doi.org/10.1186/s12885-021-08177-w

Internet

https://doi.org/10.1186/s12885-021-08177-w

Similar Items